AVANI PATEL: Open Payments
NPI 1366971970 · GLENVIEW, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$393 in 8 payments from 5 companies in 2025. Trend: 2023 $109 · 2024 $166 · 2025 $393
Food & beverage: $393
| Company | Payments | Amount |
|---|---|---|
| Ardelyx, Inc. | 4 | $144 |
| ABBVIE INC. | 1 | $124 |
| GENZYME CORPORATION | 1 | $96 |
| Janssen Biotech, Inc. | 1 | $15 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $14 |
Products named: IBSRELA, LINZESS, DUPIXENT, TREMFYA, ENTYVIO.
Industry payments across IL — which companies pay providers there.
